These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38775716)

  • 1. Efficacy and safety of irreversible electroporation in unresectable perihilar cholangiocarcinoma: a systematic review and meta-analysis.
    Scrofani AR; Valvano M; Lancellotta V; Pezzulla D; Vinci A; Cornacchione P; Bonome P; Tagliaferri L; Iezzi R
    Br J Radiol; 2024 Aug; 97(1160):1413-1422. PubMed ID: 38775716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol.
    Coelen RJS; Vogel JA; Vroomen LGPH; Roos E; Busch ORC; van Delden OM; Delft FV; Heger M; van Hooft JE; Kazemier G; Klümpen HJ; van Lienden KP; Rauws EAJ; Scheffer HJ; Verheul HM; Vries J; Wilmink JW; Zonderhuis BM; Besselink MG; van Gulik TM; Meijerink MR
    BMJ Open; 2017 Sep; 7(9):e015810. PubMed ID: 28864693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Irreversible Electroporation for Perihilar Cholangiocarcinoma: A Prospective Pilot Study.
    Franken LC; van Veldhuisen E; Ruarus AH; Coelen RJS; Roos E; van Delden OM; Besselink MG; Klümpen HJ; van Lienden KP; van Gulik TM; Meijerink MR; Erdmann JI
    J Vasc Interv Radiol; 2022 Jul; 33(7):805-813.e1. PubMed ID: 35346858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma.
    Hsiao CY; Yang PC; Li X; Huang KW
    Sci Rep; 2020 Jul; 10(1):10883. PubMed ID: 32616770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
    Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy.
    Belfiore MP; Reginelli A; Maggialetti N; Carbone M; Giovine S; Laporta A; Urraro F; Nardone V; Grassi R; Cappabianca S; Brunese L
    Med Oncol; 2020 Apr; 37(5):45. PubMed ID: 32270353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy plus concurrent irreversible electroporation improved local tumor control in unresectable hilar cholangiocarcinoma compared with chemotherapy alone.
    Ma Y; Chen Z; Zhu W; Yu J; Ji H; Tang X; Yu H; Fan L; Liang B; Li R; Li J; Li Z; Lin M; Niu L
    Int J Hyperthermia; 2021; 38(1):1512-1518. PubMed ID: 34767740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study.
    Koedijk MS; Heijmen BJM; Groot Koerkamp B; Eskens FALM; Sprengers D; Poley JW; van Gent DC; van der Laan LJW; van der Holt B; Willemssen FEJA; Méndez Romero A
    BMJ Open; 2018 Oct; 8(10):e020731. PubMed ID: 30327398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Sugumar K; Hurtado A; Naik I; Hue JJ; Rothermel LD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    HPB (Oxford); 2022 May; 24(5):586-595. PubMed ID: 35000842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma.
    Martin EK; Bhutiani N; Egger ME; Philips P; Scoggins CR; McMasters KM; Kelly LR; Vitale GC; Martin RCG
    HPB (Oxford); 2018 Nov; 20(11):1092-1097. PubMed ID: 30057125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.
    Gupta P; Maralakunte M; Sagar S; Kumar-M P; Bhujade H; Chaluvashetty SB; Kalra N
    Eur Radiol; 2021 Sep; 31(9):6511-6521. PubMed ID: 33638687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible electroporation for liver cancer ablation: A meta analysis.
    Yu M; Li S
    Eur J Surg Oncol; 2022 Jun; 48(6):1321-1330. PubMed ID: 35012834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review.
    Belkouz A; Nooijen LE; Riady H; Franken LC; van Oijen MGH; Punt CJA; Erdmann JI; Klümpen HJ
    Cancer Treat Rev; 2020 Dec; 91():102110. PubMed ID: 33075684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
    Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review.
    Charalambous P; Moris D; Karachaliou GS; Papalampros A; Dimitrokallis N; Tsilimigras DI; Oikonomou D; Petrou A
    Eur J Surg Oncol; 2020 Sep; 46(9):1565-1572. PubMed ID: 32536525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible Electroporation Treatment With Intraoperative Biliary Stenting for Unresectable Perihilar Cholangiocarcinoma: A Pilot Study.
    Yang PC; Chen YJ; Li XY; Hsiao CY; Cheng BB; Gao Y; Zhou BZ; Chen SY; Hu SQ; Zeng Q; Huang KW
    Front Oncol; 2021; 11():710536. PubMed ID: 34277454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols.
    Narayanan G; Bilimoria MM; Hosein PJ; Su Z; Mortimer KM; Martin RCG
    BMC Cancer; 2021 Jul; 21(1):785. PubMed ID: 34233640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
    Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.